Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Omollo

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Plos Neglected Tropical Diseases|October 3, 2013
Validation of two rapid diagnostic tests for visceral leishmaniasis in KenyaJane Mbui, Monique Wasunna, Manica Balasegaram, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2018
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical TrialJane Mbui, Joseph Olobo, Raymond Omollo, et al.
Trials|July 2, 2011
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trialRaymond Omollo, Neal Alexander, Tansy Edwards, et al.
Malaria Journal|January 30, 2014
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre studyBernhards R Ogutu, Kevin O Onyango, Nelly Koskei, et al.
Archives of Disease in Childhood|January 26, 2022
Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overloadChristina W Obiero, Phoebe Williams, Sheila Murunga, et al.
Plos Neglected Tropical Diseases|February 22, 2019
Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in EthiopiaErmias Diro, Tansy Edwards, Koert Ritmeijer, et al.
Plos Neglected Tropical Diseases|January 18, 2019
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in EthiopiaErmias Diro, Severine Blesson, Tansy Edwards, et al.
Plos Neglected Tropical Diseases|January 24, 2014
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialEltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, et al.
Clinical Drug Investigation|January 10, 2017
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance ProgrammeRobert Kimutai, Ahmed M Musa, Simon Njoroge, et al.
Plos Neglected Tropical Diseases|September 15, 2016
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized TrialMonique Wasunna, Simon Njenga, Manica Balasegaram, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos Neglected Tropical Diseases|October 3, 2013
Validation of two rapid diagnostic tests for visceral leishmaniasis in KenyaJane Mbui, Monique Wasunna, Manica Balasegaram, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2018
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical TrialJane Mbui, Joseph Olobo, Raymond Omollo, et al.
Trials|July 2, 2011
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trialRaymond Omollo, Neal Alexander, Tansy Edwards, et al.
Malaria Journal|January 30, 2014
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre studyBernhards R Ogutu, Kevin O Onyango, Nelly Koskei, et al.
Archives of Disease in Childhood|January 26, 2022
Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overloadChristina W Obiero, Phoebe Williams, Sheila Murunga, et al.
Plos Neglected Tropical Diseases|February 22, 2019
Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in EthiopiaErmias Diro, Tansy Edwards, Koert Ritmeijer, et al.
Plos Neglected Tropical Diseases|January 18, 2019
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in EthiopiaErmias Diro, Severine Blesson, Tansy Edwards, et al.
Plos Neglected Tropical Diseases|January 24, 2014
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialEltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, et al.
Clinical Drug Investigation|January 10, 2017
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance ProgrammeRobert Kimutai, Ahmed M Musa, Simon Njoroge, et al.
Plos Neglected Tropical Diseases|September 15, 2016
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized TrialMonique Wasunna, Simon Njenga, Manica Balasegaram, et al.
Pageof 3